Identification of Some Promising Heterocycles Useful in Treatment of Allergic Rhinitis: Virtual Screening, Pharmacophore Mapping, Molecular Docking, and Molecular Dynamics
Open Access
- 1 April 2022
- journal article
- research article
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 48 (2) , 438-456
Abstract
Rhinitis is an allergic disease that causes troubles and restlessness for patients. In this research work we will focus on finding promising organic molecules with potential ability to target histamine receptor with no sedative side effect. Phalazines and their isosteres, pyrimidines and pyridines have been reported to target H1 receptors, for this reason we have searched for library of these basic scaffolds, this library which has 184 organic molecules will be subjected for further explorations through computer aided drug design techniques. Swiss ADMET will be used to gather these compounds in clusters. Cluster with low potential to penetrate BBB is selected for virtual screening through pharmacophore model. Then molecular docking that revealed the stability of the complex formed between the investigated molecules and H1 receptor. ADMET profile showed three compounds (XVIII), (XX), and (XXI) with no toxicity on liver and no effect on CYP2D6, these three compounds were subjected to molecular dynamic simulations and compound (XVIII) showed the most stable complex with the target protein (H1). Finally, we can say this work helped us to find new compounds with promising potential to target H1 without ability to penetrate BBB, so they can be used as useful candidates in treatment of rhinitis and deserve to be subjected for preclinical and clinical investigations.Keywords
This publication has 28 references indexed in Scilit:
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better BenchmarkingJournal of Medicinal Chemistry, 2012
- The Discovery of Phthalazinone-Based Human H1and H3Single-Ligand Antagonists Suitable for Intranasal Administration for the Treatment of Allergic RhinitisJournal of Medicinal Chemistry, 2011
- Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase InhibitorJournal of Medicinal Chemistry, 2010
- Risk of first‐generation H1‐antihistamines: a GA2LEN position paperAllergy, 2010
- Rhinitis and sinusitisJournal of Allergy and Clinical Immunology, 2010
- Novel Method for Generating Structure-Based Pharmacophores Using Energetic AnalysisJournal of Chemical Information and Modeling, 2009
- The diagnosis and management of rhinitis: An updated practice parameterJournal of Allergy and Clinical Immunology, 2008
- Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and LevocetirizineClinical Pharmacokinetics, 2008
- Structural biology of allergensJournal of Allergy and Clinical Immunology, 2000
- LoratadineDrugs, 1994